Physician profile
Mark Robert Auble
NPI 1770743387
$2,581.92
in general payments reported to CMS, 2019-2025
10 companies · $655 in 2025
The $655 reported for 2025 was more than what 77% of Oral & Maxillofacial Surgery providers received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $588 · 2020: $106 · 2021: $872 · 2022: $20.95 · 2023: $83.36 · 2024: $258 · 2025: $655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $638 · Entertainment: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $637.62 |
| Entertainment | $358.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $1,235.70 | 2021-2025 | |
| Kls-Martin L.P. | $457.65 | 2022-2025 | |
| Nobel Biocare USA | $431.91 | 2019-2021 | |
| Stryker Corporation | $155.02 | 2019-2024 | Na, Patient-Fitted Tmj Reconstructive Prosthesis System, Universal Neuro 3 |
| Zimmer Biomet Holdings, INC. | $115.40 | 2019 | |
| Salvin Dental Specialties, INC. | $63.70 | 2019-2021 | |
| Patterson Companies, INC. | $56.64 | 2024 | |
| Henry Schein, INC. | $33.51 | 2024-2025 | Nuoss, Allooss Allograft Putty, Ace Surgical Supply |
| Depuy Synthes Sales INC. | $16.35 | 2023 | Matrixmidface |
| Southern Anesthesia & Surgical, INC (Dba Ace Southern) | $16.04 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Auble listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.